Pressure BioSciences (OTCQB: PBIO) is playing a major role in the war on cancer. Three out of its first five next-generation PCT-based instrument systems have been snapped up by the ProCan lab at the Children’s Medical Research Institute in Australia. U.S. Vice President Joe Biden recently named the ProCan facilities an official collaborator in the United States’ initiative – known as Cancer Moonshot (CM) – to accelerate the development of combination immunotherapies in cancer treatment. The CM program arose after Biden, whose son succumbed to the disease in 2015, promised a “moonshot” to attack cancer. The CM program has garnered widespread bipartisan support, and, earlier this month, the 21st Century Cures Act, which provides $1.8 billion in funding for the program, was signed into law. ProCan will use Pressure BioSciences’ Barococycler to prepare the 70,000-plus tumor samples it plans to analyze. This high-profile employment of the Barococycler is expected to boost the company’s revenues, which are already climbing. As of September 30, 2016, Pressure Biosciences posted three quarters of half million-dollar revenue.
To learn more, visit: www.pressurebiosciences.com - Barrons Article - Research Notes
About Pressure BioSciences, Inc. (PBI)
Pressure BioSciences, Inc. develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Its products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. To date, PBI has installed over 260 PCT systems in approximately 160 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders. PBI’s primary application development and sales efforts are in the biomarker discovery and forensics areas. Customers also use its products in other areas, such as drug discovery & design, bio-therapeutics characterization, soil & plant biology, vaccine development, histology, and forensic applications.
Please see full disclaimers on the NetworkNewsWire website: http://nnw.fm/Disclaimer